EMFACE™ TMJ is the latest FDA-cleared indication of the EMFACE platform, now officially approved to treat temporomandibular joint (TMJ) dysfunction. This means EMFACE is cleared for:
– Relief of symptoms associated with muscle spasm
– Treatment of TMJ dysfunction and associated pain
– Muscle re-education (helping facial/masticatory muscles return to healthier function)
– Increased local blood flow
– Maintenance or improvement of mandibular range of motion
EMFACE TMJ uses the same combined technologies —- radiofrequency (RF) + HIFES® (high-intensity facial electrical stimulation) — but configured to target the masseter, temporalis, and surrounding jaw musculature. It’s injectable-free, non-surgical, and now a recognized option for patients looking for relief from TMJ-related symptoms.